Introduction

The genus Serratia sp. consists of diverse bacteria that can be found across various environments, including the human body. While often categorized as opportunistic pathogens, these microorganisms exist within a complex web of host-microbe interactions. Understanding the presence of Serratia sp. across different niches helps us appreciate the delicate balance of the human gut ecosystem and other mucosal surfaces.

Location of Microbe

Primary and Secondary Distribution

Gut: Found as part of the intestinal microbial community, where it contributes to the overall metagenomic profile of the digestive tract.

Respiratory: Present in the lung microbiome and oropharyngeal region, potentially acting as a reservoir for lower respiratory colonization.

Urinary: Occurs within the urinary tract ecosystem, where its abundance can shift depending on the host's health status.

Behavior During Dysbiosis

Gut: In states of dysbiosis, such as following chemotherapy, Serratia sp. may be associated with shifts in the microbiome that correlate with the development of oral mucositis.

Respiratory: During respiratory dysbiosis, particularly in COVID-19 patients, an increased ratio of Serratia sp. in the oropharynx is associated with heightened systemic inflammation markers.

Urinary: Within the urinary ecosystem, shifts in microbial abundance of Serratia sp. are typically observed when the balance of commensal flora is disrupted, allowing opportunistic expansion.

Disease Associations

Ecosystem-Specific Associations

Respiratory Ecosystem: Serratia sp. has been identified in several critical respiratory contexts. In patients with tuberculosis (TB) and non-tuberculous mycobacterial lung diseases (NTM-LD), specific traits of Serratia sp., such as Serratia grimesii, have been noted as distinct components of the lung microbiome. Furthermore, in the context of COVID-19, an increased abundance of Serratia sp. in the oropharynx has been associated with increased disease severity and elevated neutrophil–lymphocyte ratios (NLR), suggesting a link to inflammatory signaling.

Gut/Oral Ecosystem: In pediatric oncology patients undergoing chemotherapy, the presence of Serratia sp. in the microbiome profile has been associated with the occurrence of oral mucositis (grades 1–3), indicating that chemotherapy-induced dysbiosis may facilitate its association with mucosal inflammation.

Urinary Ecosystem: As an opportunistic pathogen, Serratia sp. is associated with urinary tract imbalances, where its proliferation is often linked to compromised host defenses or the presence of indwelling devices.

Foods Supporting Healthy Balance

Maintaining a diverse gut ecosystem is key to preventing the overgrowth of opportunistic pathogens like Serratia sp. A diet rich in diverse prebiotic fibers—found in garlic, onions, leeks, and asparagus—supports the growth of beneficial bacteria that maintain gut barrier integrity and compete with opportunistic species.

Incorporating fermented foods such as kefir, sauerkraut, and kombucha introduces beneficial probiotics that help stabilize the microbial community and reduce inflammatory signaling. Additionally, focusing on polyphenol-rich foods, including berries, green tea, and dark chocolate, can modulate the gut environment to favor a balanced microbial population. Ensuring adequate intake of omega-3 fatty acids from flaxseeds or fatty fish can also support the modulation of inflammation across various mucosal surfaces, including the respiratory and urinary tracts.

Actionable Insights

Strategies for Microbial Management

• Support Diversity: Increase the intake of diverse plant-based fibers to promote a robust microbial diversity, which naturally limits the expansion of opportunistic pathogens.
• Proactive Oral Care: Given the link between oropharyngeal microbiota and respiratory health, maintaining oral hygiene can help manage the reservoir of opportunistic bacteria.
• Urinary Hygiene: Practice consistent urinary hygiene and hydration to maintain a healthy urinary ecosystem and prevent the colonization of opportunistic species.
• Mindful Antibiotic Use: Use antibiotics only when necessary and under medical supervision to avoid inducing dysbiosis that allows Serratia sp. to proliferate.
• Anti-inflammatory Diet: Emphasize a diet rich in antioxidants to support the host's inflammatory response and protect mucosal barrier integrity.

Conclusion

The role of Serratia sp. is highly dependent on the specific strain and the ecological niche it occupies. In the respiratory tract, it can be associated with markers of inflammation and severity in diseases like COVID-19 or mycobacterial infections. In the gut and oral cavities, its presence is often linked to chemotherapy-induced shifts and mucosal inflammation. In the urinary tract, it acts as an opportunistic member of the microbiome. Ultimately, the impact of Serratia sp. is governed by the overall health of the host-microbe interaction, where maintaining high microbial diversity and barrier integrity is essential for preventing dysbiosis across all these ecosystems.